Children’s Somatization Inventory (CSI-24)

1. Abstract

The Children’s Somatization Inventory (CSI-24; Walker, Beck, Garber, & Lambert, 2009) is a standardized, self-report and parent-report psychometric instrument designed to assess the presence, severity, and perceived bother of non-specific functional somatic symptoms in children and adolescents aged 8 to 18 years. Originating from the earlier 35-item questionnaire (CSI-35; Walker, Garber, & Greene, 1991), which mapped clinical somatic complaints derived from the Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R) criteria for somatization disorder, the revised 24-item form was engineered through item-response pruning to eliminate low-frequency, psychometrically redundant complaints. The instrument utilizes a 5-point Likert rating format ranging from 0 (“Not at all”) to 4 (“A whole lot”), assessing symptom interference and somatic burden over a 2-week recall window. Yielding a cumulative composite score ranging from 0 to 96, the scale evaluates diverse somatic manifestations spanning pseudoneurological, gastrointestinal, cardiorespiratory, musculoskeletal, and generalized non-specific pain sensations.

Extensive psychometric investigations substantiate the robust structural integrity, reliability, and cross-cultural validity of the CSI-24 across diverse pediatric populations. Internal consistency estimates routinely fall within an optimal threshold, with Cronbach’s alpha ($lpha$) and McDonald’s omega ($\omega$) values ranging between .84 and .92 across clinical cohorts suffering from functional abdominal pain disorders (FAPD), pediatric chronic pain syndromes, and non-clinical community youth. The 24-item iteration exhibits near-perfect concurrent validity with the original 35-item scale ($r = .99$), effectively preserving diagnostic sensitivity while diminishing respondent fatigue. Although factor-analytic inquiries exhibit structural divergence—debating between a robust unidimensional construct, multi-tiered bifactor frameworks, and truncated subscales—the instrument maintains exceptional convergent validity with validated indices of pediatric anxiety, depressive symptomatology, school impairment, and physical disability, alongside meaningful discriminant validity against organic pediatric disease. Consequently, the CSI-24 remains an internationally recognized benchmark in pediatric psychology and behavioral medicine for screening somatic distress, tracking biopsychosocial interventions, and evaluating pediatric functional disability.

2. Keywords

Children’s Somatization Inventory, CSI-24, Somatization, Pediatric Psychology, Somatic Symptom Disorder, Functional Abdominal Pain, Functional Neurological Disorder, Psychometrics, Internalizing Symptoms, Pediatric Chronic Pain, Pediatric Assessment

3. Authors

The primary investigators responsible for the conceptualization, historical development, and subsequent structural refinement of the Children’s Somatization Inventory are:

• Lynn S. Walker, Ph.D. — Professor of Pediatrics, Division of Adolescent and Young Adult Health, Department of Pediatrics; Professor of Psychology and Human Development, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Principal investigator pioneering pediatric chronic abdominal pain research and somatic symptom manifestation in pediatric behavioral medicine.
• Judy Garber, Ph.D. — Professor of Psychology and Human Development, Department of Psychology and Human Development, Peabody College, Vanderbilt University, Nashville, Tennessee, USA. Leading developmental psychopathologist focusing on adolescent depression, maternal transmission of internalizing psychopathology, and cognitive vulnerability models.
• Craig A. Greene, M.D. — Collaborating clinical investigator and pediatrician affiliated with Vanderbilt University School of Medicine, instrumental in the initial clinical operationalization of the 35-item version based on pediatric medical charts and DSM somatic symptom criteria.
• John E. Beck, M.S. — Biostatistician and quantitative methodologist, Department of Pediatrics, Vanderbilt University School of Medicine, contributing to the classical test theory and item-pruning methodologies that yielded the revised CSI-24.
• William Lambert, Ph.D. — Biostatistician and epidemiologist, contributing to longitudinal modeling, psychometric evaluation, and structural validation across pediatric cohorts at Vanderbilt University.

4. Purpose

The fundamental clinical and empirical purpose of the Children’s Somatization Inventory (CSI-24) is to systematically quantify the scope, intensity, and perceived functional distress of multiple subjective somatic complaints in children and adolescents. In pediatric medicine, recurrent physical complaints—such as chronic headaches, functional nausea, diffuse abdominal cramping, limb discomfort, and dizziness—represent one of the most frequent reasons for outpatient medical consultation, specialist referrals, and emergency department visits. Historically, clinicians struggled to differentiate organic pathophysiological conditions from psychogenic or functional manifestations without subjecting pediatric patients to an exhaustive battery of invasive, costly, and often iatrogenic medical diagnostics. The CSI-24 was engineered to address this critical diagnostic void, establishing an empirical continuum of perceived bodily distress that captures somatic distress independently of medical etiology.

Clinically, the instrument serves three vital functions. First, it operates as a standardized screening mechanism to identify youth experiencing disproportionate somatic distress, aiding in the early identification of conditions classified under the DSM-5 rubric of Somatic Symptom and Related Disorders and functional gastrointestinal disorders (such as irritable bowel syndrome and functional dyspepsia). Second, it allows multidisciplinary pediatric teams—consisting of pediatricians, pediatric gastroenterologists, child psychologists, and physical therapists—to benchmark functional impairment and avoid the cyclical escalation of diagnostic workups for non-organic symptoms. Third, by virtue of its dual parallel forms (child self-report and parent proxy-report), the instrument facilitates the diagnostic examination of perceptual discrepancies between children and their caregivers, illuminating dyadic processes such as parental catastrophic thinking, symptom hypervigilance, and inadvertent behavioral reinforcement of the sick role.

From a theoretical and research standpoint, the CSI-24 provides behavioral scientists with a psychometrically stable, continuous dependent variable to test complex biopsychosocial models of pediatric health. Somatization rarely exists in a diagnostic vacuum; it functions as a primary somatic manifestation of underlying distress, emotional dysregulation, and heightened autonomic sensitivity. The scale facilitates systematic epidemiological research tracking the developmental trajectories of somatic complaints from middle childhood through the transition into young adulthood. Longitudinal research utilizing the CSI-24 has demonstrated that high somatic burden during childhood significantly elevates the prospective risk of adult psychiatric disorders, chronic fatigue, widespread musculoskeletal pain, and vocational absenteeism. Additionally, the tool provides a standardized outcome metric for clinical trials assessing the efficacy of cognitive-behavioral therapy (CBT), acceptance and commitment therapy (ACT), autonomic biofeedback, and pharmacological interventions targeting pediatric functional neurological and visceral hypersensitivity disorders.

5. Psychological Construct

The core psychological construct measured by the CSI-24 is somatization—defined in pediatric psychometrics as the tendency to experience, endorse, and communicate psychological distress, autonomic arousal, or neurobiological vulnerability in the form of physical and somatic symptoms, accompanied by seeking medical care for symptoms that lack a demonstrable structural or organic etiology. Although the original DSM-III-R framework conceptualized somatization within a categorical psychiatric paradigm focused on hysterical or conversion features, contemporary pediatric psychology views somatization as a multi-system dimensional construct. This construct captures heightened visceral and somatic sensitivity, neurosensory amplification, and cognitive-affective distress channeled through physiological pathways.

Rather than evaluating a single isolated pain complaint, the CSI-24 evaluates the cumulative load of diverse somatic perceptions across several primary physiological clusters:

• Gastrointestinal Distress: Symptoms localized to the gastrointestinal tract, including sensations of nausea, stomach pain, abdominal distention, vomiting, constipation, and loose stools. Within functional abdominal pain disorders, this dimension reflects gut-brain axis dysregulation, visceral hyperalgesia, and heightened interoceptive awareness.
• Cephalic and Musculoskeletal Sensations: Manifestations including localized headaches, generalized muscle soreness, neck pain, stiffness, and joint aches. These items tap into myofascial tension, lowered systemic pain thresholds, and somatic amplification linked to prolonged physiological stress responses.
• Pseudoneurological and Vestibular Perturbations: Subjective experiences of dizziness, lightheadedness, weakness in the limbs, numbness, tingling sensations, or balance disturbances. These items evaluate central nervous system hyperexcitability and functional vestibular distress that frequently co-occur with autonomic instability.
• Cardiorespiratory and Autonomic Arousal: Physical symptoms that mimic sympathetic nervous system hyperarousal, including rapid heart palpitations, subjective sensations of chest tightness, breathlessness, and hot or cold flashes. These complaints capture the visceral bridge between panic spectrum sensations and pediatric somatic reactivity.
• Generalized Asthenia and Fatigue: Pervasive perceptions of low energy, systemic physical exhaustion, and feeling heavy or chronically tired despite adequate sleep, representing the neurovegetative and neuroendocrine facets of somatic distress.

In the CSI-24, these somatic complaints are assessed not merely by their binary presence or absence, but by the magnitude of subjective distress or interference they impose on the youth (i.e., “how much were you bothered by…”). This distinguishes the CSI-24 construct from medical checklists that enumerate organic illnesses; it quantifies the subjective burden and interoceptive hypervigilance that characterize pediatric functional impairment.

6. Theoretical Framework

The Children’s Somatization Inventory is situated within the intersection of developmental psychopathology, behavioral medicine, and the classical Biopsychosocial Model originally articulated by George Engel (1977). This framework rejects Cartesian mind-body dualism, positing that pediatric somatic complaints arise from continuous, bidirectional transactions among neurobiological vulnerabilities, psychological cognitive-affective factors, and contextual social environments.

Central to the theoretical underpinnings of the CSI-24 is Arthur Barsky’s Somatosensory Amplification Theory (Barsky & Wyshak, 1990). This paradigm posits that individuals with high somatic symptom burden exhibit a cognitive-perceptual style characterized by three interrelated dynamics: hypervigilant monitoring of normal internal bodily sensations, a tendency to focus on benign or ambiguous physiological noise (such as peristalsis or muscle twitching), and a catastrophic cognitive disposition to interpret these baseline visceral signals as indicative of serious medical pathology. In pediatric cohorts, this somatosensory amplification leads to a neurosensory feedback loop: fear of physical symptoms activates the sympathetic nervous system, inducing somatic changes (e.g., tachycardia, splanchnic vasoconstriction) that confirm the child’s catastrophic expectations.

Complementing this individual cognitive-perceptual model is the Social-Learning and Family Systems Model of Pediatric Illness Behavior formulated by Lynn S. Walker and colleagues (Walker et al., 1991, 2009). This developmental framework posits that somatic presentation in youth is deeply shaped by familial reinforcement patterns and parental modeling. Children of parents who exhibit high levels of somatization, health anxiety, or chronic pain frequently adopt similar somatizing illness behaviors through vicarious observation. Furthermore, parental protective behaviors—such as allowing school avoidance, providing immediate material incentives during symptom flares, and engaging in frequent medical consultations—unintentionally reinforce the sick role. Over time, these dynamic family responses entrench somatic expression as the primary coping mechanism for academic, social, or emotional stressors.

Finally, modern neurobiological models of the gut-brain axis and central sensitization provide physiological grounding for the construct measured by the CSI-24. Chronic psychological stress in early life disrupts hypothalamic-pituitary-adrenal (HPA) axis functioning, alters descending central pain modulation, and heightens visceral interoception. The CSI-24 captures the diverse phenomenology resulting from this sensitized nervous system, where psychological strain and neurophysiological reactivity produce persistent somatic distress in children.

7. Validity

The psychometric validity of the CSI-24 has been rigorously evaluated across clinical pediatric cohorts, community schools, and international cross-cultural samples, establishing robust construct, convergent, discriminant, and predictive validity.

Convergent Validity

The CSI-24 demonstrates exceptional convergent validity with other self-report and clinician-rated measures of pediatric internalizing pathology and functional impairment. In the primary validation study by Walker, Beck, Garber, and Lambert (2009), the CSI-24 correlated almost perfectly with its parent instrument, the CSI-35 ($r = .99, p < .001$), demonstrating t\hat the psychometric properties of the original scale were retained despite reducing item burden. When evaluated alongside affective metrics, the CSI-24 displays moderate to strong positive correlations with validated child anxiety scales (such as the Multidimensional Anxiety Scale for Children [MASC] and the Screen for Child Anxiety Related Disorders [SCARED]), with correlation coefficients routinely ranging from$r = .45$ to $r = .68$ ($p < .001$). Similarly, correlations with depressive symptom metrics (e.g., Child Depression Inventory [CDI]) consistently hover between$r = .40$ and $r = .60$, supporting the theoretical integration of somatization within the broader internalizing spectrum.

Moreover, convergent validity is reinforced through strong associations with functional impairment indices. Research by Lavigne, Saps, and Bryant (2012) in large community cohorts identified robust correlations between CSI-24 scores and the Functional Disability Inventory (FDI; $r = .50$ to $.65$), confirming that elevated somatization scores directly track physical limitations, school absenteeism, and restricted recreational participation.

Discriminant Validity

The scale maintains demonstrable discriminant validity by successfully distinguishing between children with functional pain disorders and those without somatic pathology. Walker et al. (2009) demonstrated that children diagnosed with functional abdominal pain disorders (FAPD) endorsed significantly higher CSI-24 total scores compared to both healthy control children ($d > 1.20$) and children presenting with well-defined, acute organic illnesses where somatic amplification is absent. Additionally, multi-trait multi-method analyses confirm that while the CSI-24 moderately correlates with general anxiety and depressive constructs, its unique variance remains distinct from externalizing behavioral manifestations—such as conduct problems or attention-deficit/hyperactivity traits—with correlations rarely exceeding $r = .15$.

Predictive and Longitudinal Validity

Longitudinal investigations confirm that baseline CSI-24 composite scores possess substantial prospective prognostic utility. In pediatric clinical samples, elevated baseline CSI-24 scores reliably predict protracted recovery periods, persistence of chronic abdominal or musculoskeletal pain into young adulthood, elevated healthcare resource utilization, and persistent functional disability up to five and ten years post-initial clinical presentation. Cerutti et al. (2017) demonstrated that higher CSI-24 scores in middle childhood predict secondary decrements in health-related quality of life (HRQoL) and increased risk for comorbid generalized anxiety disorder in late adolescence.

8. Reliability

The reliability of the CSI-24 has been thoroughly confirmed across multiple research contexts, demonstrating high internal consistency and stability across diverse samples.

Internal Consistency

Classical test theory reliability analyses show high internal consistency across both child self-report and parent proxy-report versions. In the foundational validation by Walker et al. (2009), Cronbach’s alpha for the overall CSI-24 scale was $lpha = .88$ in a large clinical cohort of pediatric patients presenting with functional chronic abdominal pain, and $lpha = .89$ in a non-clinical community sample. Further empirical replication by Lavigne, Saps, and Bryant (2012) yielded alpha values spanning $lpha = .84$ to $.91$ across cross-validation cohorts of elementary and middle school students. Parallel investigations across non-English translations have confirmed this reliability profile: the validated Spanish adaptation of the CSI-24 (Orgilés & Espada, 2014) documented a Cronbach’s alpha of $.87$, whereas Italian clinical investigations reported composite reliability metrics ranging from $lpha = .88$ to $.92$ (Cerutti et al., 2017). Across these investigations, corrected item-total correlations remained consistently above $.30$, with the majority exceeding $.45$, indicating that each individual item contributes meaningfully to the overall somatic composite without redundancy.

Test-Retest Stability

Temporal stability assessments have yielded robust test-retest reliability coefficients over various time horizons. Over short intervals (e.g., two weeks), test-retest reliability intraclass correlation coefficients (ICCs) consistently range between $r_{tt} = .65$ and $.82$ in medically stable pediatric samples, indicating strong measurement stability while remaining sensitive to dynamic clinical improvements following psychological intervention. Over longer longitudinal intervals (e.g., three to six months), coefficients moderate to approximately $r_{tt} = .50$ to $.60$, reflecting normative developmental fluctuations and natural symptom waxing and waning typical of pediatric functional disorders.

Inter-Rater Agreement

Given the availability of both child self-report and parent proxy-report forms, cross-informant reliability has been extensively quantified. Pearson correlations between child and maternal ratings typically hover between $r = .40$ and $.55$ in community settings, and slightly higher ($r = .50$ to $.65$) in clinical cohorts (Walker et al., 2009; Cerutti et al., 2017). This moderate inter-rater agreement is consistent with meta-analytic benchmarks for internalizing constructs, where internal subjective sensations are systematically underreported by parents in non-clinical environments, but frequently amplified by caregivers in clinical settings due to heightened parental anxiety and observation of severe functional impairment.

9. Factor Analysis

The latent factorial architecture of the CSI-24 has generated notable empirical discussion, revolving around whether somatic distress is best modeled as a single dimensional continuum, a multidimensional structure reflecting bodily systems, or an integrated bifactor configuration.

Exploratory Factor Analysis (EFA)

During the original development of the CSI-35, exploratory factor extractions yielded mixed solutions with cross-loadings across gastrointestinal, pain, and pseudoneurological indicators. In the 2009 refinement to the CSI-24, Walker and colleagues utilized item-response filtering and EFA to extract a dominant primary factor that accounted for the vast majority of common variance. The 11 items eliminated from the 35-item version exhibited low factor loadings ($lambda < .30$) and low base rates of endorsement (such as deafness, blindness, and aphonia). The resulting 24-item pool converged on a dominant general somatization factor, with standardized factor loadings ranging from$.35$ to $.72$.

Confirmatory Factor Analysis (CFA) and Model Fit

Subsequent structural validation of the CSI-24 has produced divergent structural models depending on the population examined:

• Unidimensional Model: Walker et al. (2009) proposed that the CSI-24 functions as a unidimensional instrument reflecting general somatic distress. While standardized loadings are uniform and positive, conventional strict goodness-of-fit indices for the single-factor model sometimes fall below target thresholds in large community cohorts (e.g., Comparative Fit Index [CFI] $\approx .85 – .88$, Root Mean Square Error of Approximation [RMSEA] $\approx .07 – .09$). This reflects significant residual covariation among biologically linked symptom clusters (such as nausea and stomach aches).
• Multidimensional Models: Lavigne, Saps, and Bryant (2012) re-examined the CSI-24 factor structure in a large community sample ($N > 1,200$) using CFA. They tested multiple competing structural configurations, finding that a four-factor correlated model provided superior fit over the unidimensional model (CFI $= .92$, TLI $= .91$, RMSEA $= .048$). The four extracted dimensions included:
  1. Gastrointestinal Symptoms (e.g., nausea, stomach pain, vomiting)
  2. Pseudoneurological / Sensory Symptoms (e.g., dizziness, blurred vision, numbness)
  3. Pain / Musculoskeletal Symptoms (e.g., limb pain, back pain, joint soreness)
  4. Cardiorespiratory / General Arousal (e.g., heart racing, chest pain, shortness of breath)
• Bifactor Model: Recent psychometric investigations favor a bifactor structure comprising a general “Somatic Distress” factor ($G$-factor) alongside orthogonal, group-specific somatic sub-factors. In bifactor CFA models, the general somatization factor accounts for more than 75% of the common variance (Omega Hierarchical, $\omega_h > .80$), supporting the empirical practice of calculating a single global score for clinical screening, while acknowledging the physiological variance of specific symptom clusters.
• Truncated Brief Forms: In response to model fit limitations of the full 24-item instrument in community populations, Orgilés and Espada (2014) isolated a 6-item unidimensional core subscale that demonstrated robust fit indices (CFI $= .98$, RMSEA $= .038$) and high reliability, isolating the most frequent somatic manifestations in pediatric samples.

10. Instrument / Measurement Tool

The operational specifications of the Children’s Somatization Inventory (CSI-24) are structured as follows:

• Instrument Type: Standardized self-report rating scale (child-report) and parallel observer-report (parent/caregiver-report).
• Target Population: Children and adolescents aged 8 to 18 years. (Parent-report forms may be completed by proxy for younger children down to age 6).
• Number of Items: 24 physical and functional symptom items.
• Administration Time: Approximately 5 to 10 minutes.
• Reading Level: Estimated at a 3rd-grade reading level (Flesch-Kincaid grade level $\approx 3.2$), utilizing accessible child-friendly descriptions of bodily complaints.
• Recall Period: Symptoms experienced during the preceding 2 weeks (14 days).
• Response Format: 5-point Likert rating scale, coded numerically as follows:
  • 0 = Not at all
  • 1 = A little
  • 2 = Some
  • 3 = A lot
  • 4 = A whole lot
• Scoring Methodology:
  • Continuous Cumulative Score: Items are summed directly to produce a global somatization severity composite score ranging from 0 to 96. Higher scores reflect greater somatic burden, interoceptive distress, and functional symptom bother.
  • Missing Data Imputation: If fewer than 20% of items (i.e., $le 4$ items) are missing, standard scoring replaces missing items with the mean of completed items. Protocols with $ge 5$ missing items are typically flagged as invalid.
  • Binary Symptom Count (Alternative Scoring): Some clinical paradigms recode responses dichotomously, counting symptoms endorsed as clinically meaningful (ratings of $ge 2$, representing “Some” or higher) to calculate the total number of distinct bothersome somatic complaints.

11. Permissions & Fee and Test Year

The revised Children’s Somatization Inventory (CSI-24) was formally published in 2009 by Lynn S. Walker and colleagues, evolving from the original 35-item scale first introduced in 1991. The instrument is considered non-commercial academic property developed with public research support through the National Institutes of Health (NIH). As such, it is made broadly accessible for academic, clinical, and non-commercial research purposes without charging royalty fees. The measure is frequently accessed directly from scholarly publications or by contacting the primary investigator, Dr. Lynn S. Walker, through Vanderbilt University Medical Center. Commercial applications, widespread inclusion in fee-for-service electronic medical platforms, or large-scale clinical trials funded by commercial entities typically require formal written authorization from the copyright holders.

12. References

• Barsky, A. J., & Wyshak, G. (1990). Hypochondriasis and somatosensory amplification. The British Journal of Psychiatry, 157(3), 404–409. https://doi.org/10.1192/bjp.157.3.404
• Cerutti, R., Spensieri, V., Valastro, C., Presaghi, F., & Guidetti, V. (2017). A comprehensive approach to understand somatic symptoms and their impact on emotional and psychosocial functioning in children. PLOS ONE, 12(2), e0171867. https://doi.org/10.1371/journal.pone.0171867
• Engel, G. L. (1977). The need for a new medical model: A challenge for biomedicine. Science, 196(4286), 129–136. https://doi.org/10.1126/science.847460
• Laird, K. T., Sherman, A. L., Smith, C. A., & Walker, L. S. (2015). Validation of the Abdominal Pain Index using a revised scoring method. Journal of Pediatric Psychology, 40(5), 517–525. https://doi.org/10.1093/jpepsy/jsu118
• Lavigne, J. V., Saps, M., & Bryant, F. B. (2012). Reexamining the factor structure of somatization using the Children’s Somatization Inventory (CSI-24) in a community sample. Journal of Pediatric Psychology, 37(8), 914–924. https://doi.org/10.1093/jpepsy/jss060
• Orgilés, M., & Espada, J. P. (2014). Spanish version of the Children’s Somatization Inventory: Factorial structure and psychometric properties in a community sample. International Journal of Behavioral Medicine, 21(3), 556–560. https://doi.org/10.1007/s12529-013-9335-9
• Walker, L. S., Beck, J. E., Garber, J., & Lambert, W. (2009). Children’s Somatization Inventory: Properties of the revised form (CSI-24). Journal of Pediatric Psychology, 34(4), 430–440. https://doi.org/10.1093/jpepsy/jsn093
• Walker, L. S., Garber, J., & Greene, C. A. (1991). Somatization symptoms in pediatric abdominal pain patients: Relation to chronic pain, psychological distress, and family history. Journal of Abnormal Child Psychology, 19(4), 379–394. https://doi.org/10.1007/BF00919084

13. Items of the Scale